Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006913 · ClinicalTrials.gov registry record · NA
Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,273
- Enrollment target
NCT03006913: Completed NA study, sponsored by University of California, San Francisco.
NCT03006913 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,273 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03006913, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,273 participants
- Enrollment target
Study Summary
Using mixed methods, investigators will conduct a multicenter partially randomized preference noninferiority trial with high-risk English-, Spanish-, and Cantonese-speaking patients assigned by (1) patients´ preference or (2) randomization to three counseling modes: (a) in-person; (b) phone; or (c) video conference. A total of 600 patients will complete counseling and 540 will complete the final survey. Baseline and post-counseling surveys will use validated measures (adapted for literacy and language) of study outcomes. All counseling sessions will be audio-taped. A sample of 90 tapes will be analyzed for counseling content and to identify 30 participants for in-depth interviews and analysis triangulating all forms of data. Genetic counselors will be interviewed in depth to elicit their perceptions of the strengths and limitations of each counseling mode.
Primary Outcome
Will measure knowledge of hereditary breast cancer information before and after delivery of counseling modes.
Interventions
- BEHAVIORAL In-person
- BEHAVIORAL By phone
- BEHAVIORAL By video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,273 participants |
| Start Date | 2017-04-18 |
| Est. Completion | 2019-12-16 |
| Phase | NA |
What the finished NCT03006913 record still lists
NCT03006913 is an interventional study that assigns participants to a tested intervention. Its 1,273 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which In-person is the first listed.
NCT03006913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03006913 about?
NCT03006913 is a clinical study titled "Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients". Using mixed methods, investigators will conduct a multicenter partially randomized preference noninferiority trial with high-risk English-, Spanish-, and Cantonese-speaking patients assigned by (1) patients´ preference or (2) randomization to three counseling modes: (a) in-person; (b) phone; or (c) ...
What is the current status of trial NCT03006913?
This trial is currently completed. It is a NA study. The enrollment target is 1,273 participants. The study started on 2017-04-18. Estimated completion is 2019-12-16.
What interventions are being tested in trial NCT03006913?
The interventions under investigation include: In-person (BEHAVIORAL), By phone (BEHAVIORAL), By video (BEHAVIORAL).
Who is sponsoring clinical trial NCT03006913?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03006913's enrollment target sits among peer trials
1,273 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI